Open AccessComparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts
Author(s) -
Karine Provost,
Leonardo Iaccarino,
David N. SoleimaniMeigooni,
Suzanne L. Baker,
Lauren Edwards,
Udo Eichenlaub,
Oskar Hansson,
William J. Jagust,
Mustafa Janabi,
Renaud La Joie,
Orit H. LesmanSegev,
Taylor J. Mellinger,
Bruce L. Miller,
Rik Ossenkoppele,
Julie Pham,
Ruben Smith,
Ida Sonni,
Amelia Strom,
Niklas MattssonCarlgren,
Gil D. Rabinovici,
Alzheimer’s Disease Neuroimaging Initiative
Publication year - 2021
Publication title -
european journal of nuclear medicine and molecular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.313
H-Index - 163
eISSN - 1619-7089
pISSN - 1619-7070
DOI - 10.1007/s00259-020-05152-8
Subject(s) - concordance , biomarker , medicine , dementia , nuclear medicine , cognitive impairment , psychology , oncology , disease , chemistry , biochemistry
To compare rates of tau biomarker positivity (T-status) per the 2018 Alzheimer's Disease (AD) Research Framework derived from [ 18 F]flortaucipir (FTP) PET visual assessment, FTP quantification, and cerebrospinal fluid (CSF) phosphorylated Tau-181 (PTau181).